Нейроэндокринные неоплазии поджелудочной железы
Диссертация
В странах Европейского Союза и в Соединенных Штатах Америки опухоли поджелудочной железы находятся на четвертом месте в структуре онкологической смертности, хотя составляют всего 2% от вновь выявленных злокачественных новообразований. Ежегодное количество вновь выявленных и умерших больных от рака поджелудочной железы практически совпадают. В России за 2007 год выявлено 14 037 больных раком… Читать ещё >
Список литературы
- Абдулкеримов З.А. «Нефункционирующие» нейроэндокринные опухоли поджелудочной железы: Дис. канд. мед наук. М 2001.
- Гуревич J1.E. Диагностика нейроэндокринных опухолей желудочно-кишечного тракта // Практическая онкология. 2005. Т.6. № 4. С. 193−201.
- Давыдов М.И., Аксель Е. М. Статистика злокачественных новообразований в России и странах СНГ в 2007 г. // Вестник РОНЦ им. H.H. Блохина РАМН. 2009. Т. 20. № 3. С. 4 158.
- Данилов М.В., Федоров В. Д. Хирургия поджелудочной железы. // М.-Медицина. 1995. 512с.
- Егоров A.B., Кузин Н. М. Вопросы диагностики нейроэндокринных опухолей поджелудочной железы // Практическая онкология. 2005. Т.6. № 4. С. 206−212.
- Егоров A.B., Кузин Н. М., Ветшев П. С. и др. Спорные и нерешенные вопросы диагностики и лечения гормонопродуцирующих нейроэндокринных опухолей поджелудочной железы // Хирургия. 2005. № 9. С. 19−24.
- Имянитов E.H. Эпидемиология и биология нейроэндокринных опухолей // Практическая онкология. 2005. Т. 6. № 4. С. 202−205.
- Кармазановский Г. Г., Федоров В. Д. Компьютерная томография поджелудочной железы и органов забрюшинного пространства. // М.: Русский Дом. 2002. С. 86−98.
- Кондрашин С.А., Егоров A.B., Пашкова И. Л., Майорова Е. М. Ангиография и артериально-стимулированный забор крови в топическойдиагностике органического // Радиология — диагностика и интервенция. 2008. Т. 2. № 1.С. 38−45.
- Кочатков А.В. Предоперационное стадирование и факторы прогноза при раке поджелудочной железы // Дисс. на соиск. уч. степени канд. мед. наук. Москва. 2005. С. 185.
- Кубышкин В.А., Вишневскй В. А. Рак поджелудочной железы // М.: Медпрактика. 2003. 375 с.
- Кузин Н.М., Егоров А. В. Нейроэндокринные опухоли поджелудочной железы. // М.-Медицина. 2001. С. 49−60.
- Кунцевич Г. И. Ультразвуковая диагностика в абдоминальной и сосудистой хирургии // Минск. «Кавалер Паблишере». 1999. 252 с.
- Мадан А. Ангиография и артериальностимулированный забор крови в топической диагностике органического гиперинсулинизма: Автореф.дисс.канд. мед. наук. М., 1999. 23 с.
- Привезенцева Т.В., Марков И. Н. Ангиография при инсулиномах поджелудочной железы // Вестн. рентгенологии. 1979. № 5. С. 57−62.
- Прокоп М., Галански М. Спиральная и многослойная компьютерная томография. Учебное пособие в 2-х томах под ред. Зубарева А. В., Шотемора Ш. Ш. т. 2, //М: «МЕДпресс-информ». 2007. С. 307−324.
- Сорокина O. JL в кн.: Политические деятели России 1917. биографический словарь // Москва. 1993.
- Щеголев А.И., Паклина О. В., Галил-Оглы Г.А. Опухоли поджелудочной железы // Архив патологии.-2006. Приложение. С. 1−48.
- Akazawa С. и др. A mammalian helix-loop-helix factor structurally related to the product of Drosophila proneural gene atonal is a positive transcriptional regulator expressed in the developing nervous system. // J Biol Chem. 1995. № 270. C. 8730−8738.
- Akerstrom G. h flp. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in patients with neuroendocrine tumors. // Neuroendocrinology. 2009. № 90. C. 203−208.
- Akerstrom G. h flp. Pancreatic tumours as part of the MEN-1 syndrome. // Best Pract Res Clin Gastroenterol. 2005. № 19. C. 819−830.
- Akerstrom G., Hellman P. Surgery on neuroendocrine tumours. // Best Pract Res Clin Endocrinol Metab. 2007. № 21. C. 87−109.
- Akerstrom G., Hessman O., Skogseid B. Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumors of the pancreas in MEN 1. // Langenbecks Arch Surg. 2002. № 386. C. 558−569.
- Alexander H.R. hp. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome. //Ann Surg. 1998. № 228. C. 228−238.
- Angeli E. h ap. Value of abdominal sonography and MR imaging at 0.5 T in preoperative detection of pancreatic insulinoma: a comparison with dynamic CT and angiography. // Abdom Imaging. 1997. № 22. C. 295−303.
- Anlauf M. h, np. Hereditary neuroendocrine tumors of the gastroenteropancreatic system. //Virchows Arch. 2007. № 451 Suppl. C. S29−38.
- Anlauf M. h flp. Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome. // Am J Surg Pathol. 2006. № 30. C. 560−574.
- Aranha G.V. h /jp. Zero mortality after 152 consecutive pancreaticoduodenectomies with pancreaticogastrostomy. // J Am Coll Surg. 2003. № 197. C. 222−223.
- Ardengh J.C., de Paulo G.A., Ferrari A.P. EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. // Gastrointest Endosc. 2004. № 60. C. 378−384.
- Ariyama J. h flp. Endoscopic ultrasound and intraductal ultrasound in the diagnosis of small pancreatic tumors. // Abdom Imaging. 1998. № 23. C. 380−386.
- Arnold R. Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options. // Best Pract Res Clin Gastroenterol. 2005. № 19. C. 491−505.
- Arnold R. h ap. Endocrine tumours of the gastrointestinal tract: Chemotherapy. // Best Pract Res Clin Gastroenterol. 2005. № 19. C. 649−656.
- Assalia A., Gagner M. Laparoscopic pancreatic surgery for islet cell tumors of the pancreas. // World J Surg. 2004. № 28. C. 1239−1247.
- Auernhammer C.J., Goke B. Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin. // Gut. 2011. № 60. C. 1009−1021.
- Balci N.C., Semelka R.C. Radiologic features of cystic, endocrine and other pancreatic neoplasms. // Eur J Radiol. 2001. № 38. C. 113−119.
- Bartsch D.K. h, qp. Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. // Ann Surg. 2005. № 242. C. 757−64, discussion 764−766.
- Bartsch D.K. h r p. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? // Surgery. 2000. № 128. C. 958−966.
- Beger H.G. h flp. Diseases of the pancreas current surgical therapy. // 2008. C. xi, 949 p.
- Ben-Arie N. h ap. Evolutionary conservation of sequence and expression of the bHLH protein Atonal suggests a conserved role in neurogenesis. // Hum Mol Genet. 1996. № 5. C. 1207−1216.
- Bettini R. h flp. Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. // Dig Liver Dis. 2009. № 41. C. 49−55.
- Binkovitz L.A., Johnson C.D., Stephens D.H. Islet cell tumors in von Hippel-Lindau disease: increased prevalence and relationship to the multiple endocrine neoplasias. // AJR Am J Roentgenol. 1990. № 155. C. 501−505.
- Bishop A.E. h flp. Neuron specific enolase: a common marker for the endocrine cells and innervation of the gut and pancreas. // Gastroenterology. 1982. № 83. C. 902−915.
- Borglum Jensen T.D., Hoist J.J., Fahrenkrug J. Characterization of immunoreactive pancreastatin in porcine tissues. // Scand J Clin Lab Invest. 1991. № 51. C. 681−691.
- Bosman F.T., World Health Organization., International Agency for Research on Cancer. WHO classification of tumours of the digestive system. Lyon: International Agency for Research on Cancer, 2010. Bun. 4th.
- Broder L.E., Carter S.K. Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients. // Ann Intern Med. 1973. № 79. C. 108— 118.
- Broughan T.A. h ap. Pancreatic islet cell tumors. // Surgery. 1986. № 99. C. 671−678.
- Buetow P.C. h ap. Islet cell tumors of the pancreas: clinical, radiologic, and pathologic correlation in diagnosis and localization. // Radiographics. 1997. № 17. C. 453−72- quiz 472A-472B.
- Cadiot G. h pp. Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Groupe D’etude Du Syndrome De Zollinger-Ellison. // Gastroenterology. 1996. № 111. C. 845 854.
- Cameron J.L. h? p. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. // Ann Surg. 1993. № 217. C. 430 438.
- Caplin M., Kvols L. Handbook of Neuroendocrine Tumors: Their Current and Future Management. BioScientifica, 2007.
- Capurso G. h ap. Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review. // Neuroendocrinology. 2011. № 93. C. 223−229.
- Carlson B. h ap. MRI of pancreatic islet cell carcinoma. // J Comput Assist Tomogr. 1993. № 17. C. 735−740.
- Carty S.E., Jensen R.T., Norton J.A. Prospective study of aggressive resection of metastatic pancreatic endocrine tumors. // Surgery. 1992. № 112. C. 1022−1024.
- Casadei R. h flp. Value of both WHO and TNM classification systems for patients with pancreatic endocrine tumors: results of a single-center series. // World J Surg. 2009. № 33. C. 2458−2463.
- Casanovas O. h Ap. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. // Cancer Cell. 2005. № 8. C. 299−309.
- Chamberlain R.S. h ap. Hepatic neuroendocrine metastases: does intervention alter outcomes? // J Am Coll Surg. 2000. № 190. C. 432145.
- Chandrasekharappa S.C. h ap. Positional cloning of the gene for multiple endocrine neoplasia-type 1. // Science. 1997. № 276. C. 404−407.
- Chen H. h flp. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? // J Am Coll Surg. 1998. № 187. C. 83−88.
- Cheslyn-Curtis S., Sitaram V., Williamson R.C. Management of nonfunctioning neuroendocrine tumours of the pancreas. // Br J Surg. 1993. № 80. C. 625−627.
- Chiti A. h ap. Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours. //Eur J Nucl Med. 1998. № 25. C. 1396−1403.
- Chou Y.H. h? p. Solitary metastasis from renal cell carcinoma presenting as diffuse pancreatic enlargement. // J Clin Ultrasound. 2002. № 30. C. 499−502.
- Chu Q.D. h? ip. Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas. // Ann Surg Oncol. 2002. № 9. C. 855−862.
- Chung J.C. h AP- Localization and surgical treatment of the pancreatic insulinomas. // ANZ J Surg. 2006. № 76. C. 1051−1055.
- Codd E.F. A relational model of data for large shared data banks. 1970. // MD Comput. 1998. № 15. C. 162−166.
- Collen M.J. h flp. Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion. // Ann Intern Med. 1984. № 100. C. 52−58.
- Connolly M.M. h flp. Survival in 1001 patients with carcinoma of the pancreas. // Ann Surg. 1987. № 206. C. 366−373.
- Corleto V.D. h flp. Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome? // Aliment Pharmacol Ther. 2001. № 15. C. 1555−1561.
- Cougard P. h flp. Insulinomas in multiple endocrine neoplasia type 1. Report of a series of 44 cases by the multiple endocrine neoplasia study group. // Ann Chir. 2000. № 125. C. 118−123.
- Couvelard A. hp. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. // Br J Cancer. 2005. № 92. C. 94−101.
- Creutzfeldt W. Carcinoid tumors: development of our knowledge. // World J Surg. 1996. № 20. C. 126−131.
- Curley S.A. h jxp. Surgical decision-making affected by clinical and genetic screening of a novel kindred with von Hippel-Lindau disease and pancreatic islet cell tumors. // Ann Surg. 1998. № 227. C. 229−235.
- Curry W.J. h, ap. Distribution and partial characterisation of immunoreactivity to the putative C-terminus of rat pancreastatin. // Regul Pept. 1990. № 30. C. 207−219.
- Cwikla J.B. h flp. Diagnostic imaging of carcinoid metastases to the abdomen and pelvis. // Med Sci Monit. 2004. № 10 Suppl 3. C. 9−16.
- David A.W. h, ap. Pancreatic metastasis from renal cell carcinoma 16 years after nephrectomy: a case report and review of the literature. // Trop Gastroenterol. 2006. № 27. C. 175−176.
- De Angelis C. h ap. Endosonography in decision making and management of gastrointestinal endocrine tumors. // Eur J Ultrasound. 1999. № 10. C. 139−150.
- Debelenko L.V. h pp. Allelic deletions on chromosome llql3 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. // Cancer Res. 1997. № 57. C. 2238−2243.
- DeLellis R.A. hp. World Health Organization classification of tumours, pathology and genetics of tumours of endocrine organs. Lyon: IARC, 2004.
- Delle Fave G. hp. ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. // Neuroendocrinology. 2012. № 95. C. 74−87.
- Demeure M.J. h, ztp. Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach. // Surgery. 1991. № 110. C. 995−998.
- DeOliveira M.L. h ap. Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. // Ann Surg. 2006. № 244. C. 931−939.
- Diakatou E. h flp. Somatostatin and dopamine receptor profile of gastroenteropancreatic neuroendocrine tumors: an immunohistochemical study. // Endocr Pathol. 2011. № 22. C. 24−30.
- Dial P.F. h #p. Management of nonfunctioning islet cell tumors of the pancreas. // Surg Clin North Am. 1985. № 65. C. 291−299.
- Diaz Perez J.A. Neuroendocrine system of the pancreas and gastrointestinal tract: origin and development. // Endocrinol Nutr. 2009. № 56 Suppl 2. C. 2−9.
- Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. // Ann Surg. 2004. № 240. C. 205−213.
- Donow C. h flp. Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy. // Cancer. 1991. № 68. C. 1329−1334.
- Dralle H. h? tp. Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors. // World J Surg. 2004. № 28. C. 1248−1260.
- Duerr E.M. hp. Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis. // Endocr Relat Cancer. 2008. № 15. C. 243−256.
- Duerr E.M., Chung D.C. Molecular genetics of neuroendocrine tumors. // Best Pract Res Clin Endocrinol Metab. 2007. № 21. C. 1−14.
- Edge S.B., Compton C.C. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. // Ann Surg Oncol. 2010. № 17. C. 1471−1474.
- Eriksson B. hp. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: chemotherapy in patients with neuroendocrine tumors. // Neuroendocrinology. 2009. № 90. C. 214−219.
- Eriksson B. h rp. Neuroendocrine pancreatic tumours: clinical presentation, biochemical and histopathological findings in 84 patients. // J Intern Med. 1990. № 228. C. 103−113.
- Evans D.B. hp. Nonfunctioning islet cell carcinoma of the pancreas. // Surgery. 1993. № 114. C. 1172−1175.
- Falconi M. h, ap. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. // Neuroendocrinology. 2012. № 95. C. 120−134.
- Falconi M. hp. Well-differentiated pancreatic nonfunctioning tumors/carcinoma. // Neuroendocrinology. 2006. № 84. C. 196−211.
- Faure J.P. h zip. Pancreatic metastasis of renal cell carcinoma: presentation, treatment and survival. //J Urol. 2001. № 165. C. 20−22.
- Fernandez-Cruz L. h pp. Outcome of laparoscopic pancreatic surgery: endocrine and nonendocrine tumors. // World J Surg. 2002. № 26. C. 1057−1065.
- Fidler J.L. h ap. Preoperative detection of pancreatic insulinomas on multiphasic helical CT. // AJR Am J Roentgenol. 2003. № 181. C. 775−780.
- Fidler J.L., Johnson C.D. Imaging of neuroendocrine tumors of the pancreas. // Int J Gastrointest Cancer. 2001. № 30. C. 73−85.
- Finlayson E., Clark O.H. Surgical treatment of insulinomas. // Surg Clin North Am. 2004. № 84. C. 775−785.
- Fishbeyn V.A. h Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach. // Ann Intern Med. 1993. № 119. C. 199−206.
- Galiber A.K. h #p. Localization of pancreatic insulinoma: comparison of pre- and intraoperative US with CT and angiography. // Radiology. 1988. № 166. C. 405108.
- Gauger P.G. hp. Role of endoscopic ultrasonography in screening and treatment of pancreatic endocrine tumours in asymptomatic patients with multiple endocrine neoplasia type 1. // Br J Surg. 2003. № 90. C. 748−754.
- Gibril F. h ap. Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. // Medicine (Baltimore). 2004. № 83. C. 43−83.
- Gibril F. h flp. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. // Ann Intern Med. 1996. № 125. C. 26−34.
- Gibril F., Jensen R.T. Advances in evaluation and management of gastrinoma in patients with Zollinger-Ellison syndrome. // Curr Gastroenterol Rep. 2005. № 7. C. 114−121.
- Gibril F., Jensen R.T. Diagnostic uses of radiolabeled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours. // Dig Liver Dis. 2004a. № 36 Suppl l.C. SI06−20.
- Gibril F., Jensen R.T. Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion. // Curr Gastroenterol Rep. 2004b. № 6. C. 454−463.
- Gilbert C.M. h flp. Endoscopic ultrasound-guided fine-needle aspiration of metastases to the pancreas: A study of 25 cases. // Cytojournal. 2011. № 8. C. 7.
- Giovannini M. The place of endoscopic ultrasound in bilio-pancreatic pathology. // Gastroenterol Clin Biol. 2010. № 34. C. 436−445.
- Givi B. h flp. Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival. // Surgery. 2006. № 140. C. 891−898.
- Godwin 2nd J.D. Carcinoid tumors. An analysis of 2,837 cases. // Cancer. 1975. № 36. C. 560−569.
- Gouya H. h, ap. CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. // AJR Am J Roentgenol. 2003. № 181. C. 987−992.
- Gradwohl G. hp. neurogenic is required for the development of the four endocrine cell lineages of the pancreas. // Proc Natl Acad Sci USA. 2000. № 97. C. 1607−1611.
- Grama D. h flp. Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes. // World J Surg. 1992. № 16. C. 632−639.
- Granberg D. h zip. Treatment of liver metastases in patients with neuroendocrine tumors. // Int J Hepatol. 2012. № 2012. C. 790 635.
- Grant C.S. Gastrointestinal endocrine tumours. Insulinoma. // Baillieres Clin Gastroenterol. 1996. № 10. C. 645−671.
- Graves T.D. hp. Misdiagnosis of seizures: insulinoma presenting as adult-onset seizure disorder. // J Neurol Neurosurg Psychiatry. 2004. № 75. C. 1091— 1092.
- Guba M. h flp. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. // Nat Med. 2002. № 8. C. 128−135.
- Gullo L. h flp. Do early symptoms of pancreatic cancer exist that can allow an earlier diagnosis? // Pancreas. 2001. № 22. C. 210−213.
- Halfdanarson T.R. hp. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. // Ann Oncol. 2008. № 19. C. 1727−1733.
- Harring T.R. h flp. Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review. // Int J Hepatol. 2011. № 2011. C. 154 541.
- Hellman P. hp. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. // World J Surg. 2002. № 26. C. 991−997.
- Hellman P. h flp. Endoscopic ultrasonography for evaluation of pancreatic tumours in multiple endocrine neoplasia type 1. // Br J Surg. 2005. № 92. C. 1508— 1512.
- Hellman P. h flp. Surgical strategy for large or malignant endocrine pancreatic tumors. // World J Surg. 2000. № 24. C. 1353−1360.
- Henne-Bruns D. h ap. Surgery for ductal adenocarcinoma of the pancreatic head: staging, complications, and survival after regional versus extended lymphadenectomy. // World J Surg. 2000. № 24. C. 592−595.
- Hercot O. h AP- Diagnosis of glucagonoma. Value of scanning, echography and arteriography. Apropos of 2 cases and a review of the literature. // J Radiol. 1989. № 70. C. 309−316.
- Hill M.E., Asa S.L., Drucker D.J. Essential requirement for Pax6 in control of enteroendocrine proglucagon gene transcription. // Mol Endocrinol. 1999. № 13. C.1474−1486.
- Hochwald S.N. h flp. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. // J Clin Oncol. 2002. № 20. C. 2633−2642.
- Hoffmann K.M., Furukawa M., Jensen R.T. Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment. // Best Pract Res Clin Gastroenterol. 2005. № 19. C. 675−697.
- House M.G. h ap. Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer. // J Gastrointest Surg. 2006. № 10. C. 138−145.
- Hubalewska-Dydejczyk A. h flp. 99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years' experience. // Eur J Nucl Med Mol Imaging. 2006. № 33. C. 1123−1133.
- Jablonska B. h pp. Surgical treatment of pancreatic neuroendocrine tumours clinical experience. // Pol Przegl Chir. 2011. № 83. C. 216−222.
- Janes Jr. R.H. h, np. National patterns of care for pancreatic cancer. Results of a survey by the Commission on Cancer. // Ann Surg. 1996. № 223. C. 261—272.
- Jaroszewski D.E. h ap. Laparoscopic localization and resection of insulinomas. // Arch Surg. 2004. № 139. c. 270−274.
- Jensen R.T. Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. // J Intern Med. 1998. № 243. C. 477−488.
- Jensen R.T. h, ap. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. // Neuroendocrinology. 2012. № 95. C. 98−119.
- Jensen R.T. h? p. Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. // Cancer. 2008. № 113. C. 1807−1843.
- Jensen R.T., Delle Fave G. Promising advances in the treatment of malignant pancreatic endocrine tumors. // N Engl J Med. 2011. № 364. C. 564 565.
- Kaido T. Randomized controlled trials on hepato-biliary-pancreatic surgery. // J Hepatobiliary Pancreat Surg. 2004. № 11. C. 381−389.
- Kalra M.K. hp. State-of-the-art imaging of pancreatic neoplasms. // Br J Radiol. 2003. № 76. C. 857−865.
- Kaltsas G.A., Besser G.M., Grossman A.B. The diagnosis and medical management of advanced neuroendocrine tumors. // Endocr Rev. 2004. № 25. C. 458−511.
- Kamisawa T. h Ductal and acinar differentiation in pancreatic endocrine? tumors. // Dig Dis Sci. 2002. № 47. C. 2254−2261.
- Kann P.H. h, ap. Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study. // Endocr Relat Cancer. 2006a. № 13. C. 1195−1202.
- Karnik S.K. h ap. Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. // Science. 2007. № 318. C. 806 809.
- Kawamoto S. h flp. Small serotonin-producing neuroendocrine tumor of the pancreas associated with pancreatic duct obstruction. // AJR Am J Roentgenol. 2011.№ 197. C. W482−8.
- Kim D.H. h? p. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. // Cell. 2002. № 110. C. 163 175.
- Kimura W., Kuroda A., Morioka Y. Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. // Dig Dis Sci. 1991. № 36. C. 933 942.
- King A.D. h flp. Dual phase spiral CT in the detection of small insulinomas of the pancreas. // Br J Radiol. 1998. № 71. C. 20−23.
- Klimstra D.S. h flp. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. // Pancreas. 2010. № 39. C. 707−712.
- Kloppel G. h, np. Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients. // Cancer. 1986. № 57. C. 1824−1832.
- Kloppel G., Anlauf M. Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract. // Best Pract Res Clin Gastroenterol. 2005. № 19. C. 507−517.
- Kloppel G., Heitz P.U. Pancreatic endocrine tumors. // Pathol Res Pract. 1988. № 183. C. 155−168.
- Kollarova H. hp. Pancreas cancer epidemiology. // Epidemiol Mikrobiol Imunol. 2007. № 56. C. 38−43.
- Konstantinidis I.T. h /ip. Metastatic tumors in the pancreas in the modern era. // J Am Coll Surg. 2010. № 211. C. 749−753.
- Konukiewitz B., Enosawa T., Kloppel G. Glucagon expression in cystic pancreatic neuroendocrine neoplasms: an immunohistochemical analysis. // Virchows Arch. 2011. № 458. C. 47−53.
- Kouvaraki M.A. hp. Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas. // J Clin Oncol. 2004. № 22. C. 4762−4771.
- Kouvaraki M.A. h? p. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. // World J Surg. 2006. № 30. C. 643−653.
- Kouvaraki M.A. h, ztp. Surgical treatment of non-functioning pancreatic islet cell tumors. // J Surg Oncol. 2005. № 89. C. 170−185.
- Krejs G.J. h flp. Somatostatinoma syndrome. Biochemical, morphologic and clinical features. // N Engl J Med. 1979. № 301. C. 285−292.
- Krenning E.P. h flp. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1 -octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. // J Nucl Med. 1992. № 33. C. 652−658.
- Kulke M.H. h flp. Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumors. // J Hematol Oncol. 2011. № 4. C. 29.
- Kumbasar B. h, ztp. Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS. // Abdom Imaging. 2004. № 29. C. 696−702.
- Rosa S. h Ap. Prognostic criteria in nonfunctioning pancreatic endocrine tumours. // Virchows Arch. 1996. № 429. C. 323−333.
- MacFarlane M.P. hp. Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1. // Surgery. 1995. № 118. C. 973−980.
- Machado N.O., Chopra P. Pancreatic metastasis from renal carcinoma managed by Whipple resection. A case report and literature review of metastatic pattern, surgical management and outcome. // JOP. 2009. № 10. C. 413−418.
- Madura J.A. h ap. Nonfunctioning islet cell tumors of the pancreas: a difficult diagnosis but one worth the effort. // Am Surg. 1997. № 63. C. 573−578.
- Marion-Audibert A.M. hp. Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. // Gastroenterology. 2003. № 125. C. 1094−1104.
- Marx S. h .zjp. Multiple endocrine neoplasia type 1: clinical and genetic topics. // Ann Intern Med. 1998. № 129. C. 484−494.
- Matsuno S. hp. Pancreatic cancer: current status of treatment and survival of 16 071 patients diagnosed from 1981−1996, using the Japanese National Pancreatic Cancer Database. // International Journal of Clinical Oncology. 2000. № 5. C. 153−157.
- Matthews B.D. h ap. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas. // Am Surg. 2000. № 66. C. 1113−1116.
- McArthur K.E. h, ap. Laparotomy and proximal gastric vagotomy in Zollinger-Ellison syndrome: results of a 16-year prospective study. // Am J Gastroenterol. 1996. № 91. C. 1104−1 111.
- McCallum R.W., Parameswaran V., Burgess J.R. Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose. // Clin Endocrinol (Oxf). 2006. № 65. C. 163−168.
- McLean A.M., Fairclough P.D. Endoscopic ultrasound in the localisation of pancreatic islet cell tumours. // Best Pract Res Clin Endocrinol Metab. 2005. № 19. C. 177−193.
- Mecho S. h flp. Pancreatic metastasis of renal cell carcinoma: multidetector CT findings. // Abdom Imaging. 2009. № 34. C. 385−389.
- Migliori M. h ap. A meal stimulation test in the diagnosis of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. // Endocrine. 2002. № 17. C. 229−232.
- Mignon M. Natural history of neuroendocrine enteropancreatic tumors. // Digestion. 2000. № 62 Suppl 1. C. 51−58.
- Modlin I.M. h ap. Gastroenteropancreatic neuroendocrine tumours. // Lancet Oncol. 2008. № 9. C. 61−72.
- Modlin I.M., Lye K.D., Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. // Cancer. 2003. № 97. C. 934−59.
- Naalsund A. h ap. Carcinoid lung tumors—incidence, treatment and outcomes: a population-based study. // Eur J Cardiothorac Surg. 2011. № 39. C. 565−569.
- Naya F.J., Stellrecht C.M., Tsai M.J. Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. // Genes Dev. 1995. № 9. C. 1009−1019.
- Newton J.N. hp. The epidemiology of carcinoid tumours in England and Scotland. // Br J Cancer. 1994. № 70. C. 939−942.
- Nilsson O. h flp. Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic). //Neuroendocrinology. 2006. № 84. C. 212−215.
- Nitecki S.S. hp. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? // Ann Surg. 1995. № 221. C. 59−66.
- Noone T.C. h flp. Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. // Best Pract Res Clin Endocrinol Metab. 2005. № 19. C. 195−211.
- Norton J.A. Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases. // Best Pract Res Clin Gastroenterol. 2005. № 19. C. 577−583.
- Norton J.A. h ap. Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. // Ann Surg. 1986. № 203. C. 352−359.
- Norton J.A. h flp. Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. // Ann Surg. 2001. № 234. C. 495−496.
- Norton J.A. h, zjp. Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment. // Surgery. 2004. № 136. C. 1267−1274.
- Norton J.A. h flp. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. // Arch Surg. 2003. № 138. C. 859−866.
- Norton J.A. h ap. Surgery increases survival in patients with gastrinoma. // Ann Surg. 2006. № 244. C. 410119.
- Norton J.A. h flp. Surgery to cure the Zollinger-Ellison syndrome. // N Engl J Med. 1999. № 341. C. 635−644.
- Norton J.A., Jensen R.T. Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome. // Ann Surg. 2004. № 240. C. 757−773.
- O’Riordain D.S. h flp. Surgical management of insulinoma associated with multiple endocrine neoplasia type I. // World J Surg. 1994. № 18. C. 484188.
- O’Toole D. h ap. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers. // Neuroendocrinology. 2009. № 90. C. 194−202.
- O’Toole D. h flp. Rare functioning pancreatic endocrine tumors. // Neuroendocrinology. 2006. № 84. C. 189−195.
- Oberg K. Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors). // Curr Opin Endocrinol Diabetes Obes. 2009. № 16. C. 72−78.
- Oberg K. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches. // Curr Opin Oncol. 2012. № 24. C. 433−440.
- Oberg K. h jvp. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biotherapy. // Neuroendocrinology. 2009. № 90. C. 209 213.
- Oberg K., Castellano D. Current knowledge on diagnosis and staging of neuroendocrine tumors. // Cancer Metastasis Rev. 2011. № 30 Suppl 1. C. 3−7.
- Oberg K., Skogseid B. The ultimate biochemical diagnosis of endocrine pancreatic tumours in MEN-1. // J Intern Med. 1998. № 243. C. 471−476.
- Oberg K.E. Gastrointestinal neuroendocrine tumors. // Ann Oncol. 2010. № 21 Suppl 7. C. vii72−80.
- Oberstein P.E. hp. Pancreatic neuroendocrine tumors: entering a new era. //JOP. 2012. № 13. C. 169−173.
- Oberstein P.E., Saif M.W. Safety and efficacy of everolimus in adult patients with neuroendocrine tumors. // Clin Med Insights Oncol. 2012. № 6. C. 41−51.
- Owen N.J. h flp. MRI of pancreatic neuroendocrine tumours. // Br J Radiol. 2001. № 74. C. 968−973.
- Palmowski M. n ap. Metastasis to the pancreas: characterization by morphology and contrast enhancement features on CT and MRI. // Pancreatology. 2008. № 8. C. 199−203.
- Pantalone D., Ragionieri I., Nesi G. Improved survival in small pancreatic cancer. // Dig Surg. 2001. № 18. C. 41−46.
- Panzuto F. h flp. Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma. // Ann Oncol. 2006. № 17. C. 461—466.
- Pape U.F. hp. Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center. // Ann N Y Acad Sci. 2004. № 1014. C. 222−233.
- Papouchado B. h ap. Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas. // Mod Pathol. 2005. № 18. C. 1329−1335.
- Park B.J. h flp. Operative management of islet-cell tumors arising in the head of the pancreas. // Surgery. 1998. № 124. C. 1052−1056.
- Pedrazzoli S. h pp. A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer. // Dig Surg. 1999. № 16. C. 337−345.
- Pendlimari R., Leonard D., Dozois E.J. Rare malignant neuroendocrine transformation of a presacral teratoma in patient with Currarino syndrome. // Int J Colorectal Dis. 2010. № 25. C. 1383−1384.
- Peng S.Y. h Ap. Diagnosis and treatment of VIPoma in China: (case report and 31 cases review) diagnosis and treatment of VIPoma. // Pancreas. 2004. № 28. C. 93−97.
- Perren A. h pp. Multiple endocrine neoplasia type 1 (MEN1): loss of one MEN1 allele in tumors and monohormonal endocrine cell clusters but not in islet hyperplasia of the pancreas. // J Clin Endocrinol Metab. 2007. № 92. C. Ill 8— 1128.
- Perry R.R., Vinik A.I. Clinical review 72: diagnosis and management of functioning islet cell tumors. // J Clin Endocrinol Metab. 1995. № 80. C. 22 732 278.
- Phan G.Q. h ap- Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: Review of 125 patients. // J Gastrointest Surg. 1998. № 2. C. 473—482.
- Pitre J. h? p. Endoscopic ultrasonography for the preoperative localization of insulinomas. // Pancreas. 1996. № 13. C. 55−60.
- Portel-Gomes G.M. hp. Chromogranin A in human neuroendocrine tumors: an immunohistochemical study with region-specific antibodies. // Am J Surg Pathol. 2001. № 25. C. 1261−1267.
- Procacci C. h ap. Nonfunctioning endocrine tumors of the pancreas: possibilities of spiral CT characterization. // Eur Radiol. 2001. № 11. C. 11 751 183.
- Proye C. h flp. Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy. // Surgery. 1998. № 124. C. 1134.
- Quaedvlieg P.F. hp. Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients. // Ann Oncol. 2001. № 12. C. 1295−1300.
- Que F.G. h flp. Hepatic resection for metastatic neuroendocrine carcinomas. // Am J Surg. 1995. № 169. C. 33−36.
- Que F.G., Sarmiento J.M., Nagorney D.M. Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors. // Adv Exp Med Biol. 2006. № 574. C. 43−56.
- Ramage J.K. h flp. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. // Gut. 2005. № 54 Suppl 4. C. ivl— 16.
- Ramage J.K. hp. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). // Gut. 2012. № 61. C. 632.
- Rappeport E.D. hp. Multidetector computed tomography and neuroendocrine pancreaticoduodenal tumors. // Acta Radiol. 2006. № 47. C. 248 256.
- Rasbach D.A. h flp. Surgical management of hyperinsulinism in the multiple endocrine neoplasia, type 1 syndrome. // Arch Surg. 1985. № 120. C. 584−589.
- Raufman J.P. h, ap. Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome. // Gastroenterology. 1983. № 84. C. 108−113.
- Reddy S. h ap. Pancreatic resection of isolated metastases from nonpancreatic primary cancers. // Ann Surg Oncol. 2008. № 15. C. 3199−3206.
- Reynolds C. hp. Somatostatinoma—the most recently described pancreatic islet cell tumor. // West J Med. 1985. № 142. C. 393−397.
- Reznek R.H. CT/MRI of neuroendocrine tumours. // Cancer Imaging. 2006. № 6. C. SI63−77.
- Rha S.E. h a p. CT and MR imaging findings of endocrine tumor of the pancreas according to WHO classification. // Eur J Radiol. 2007. № 62. C. 371— 377.
- Rickes S., Monkemuller K., Malfertheiner P. Contrast-enhanced ultrasound in the diagnosis of pancreatic tumors. //JOP. 2006. № 7. C. 584−592.
- Rindi G. h flp. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. // Virchows Arch. 2006. № 449. C. 395−401.
- Rindi G. h ap. TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study. // J Natl Cancer Inst. 2012. № 104. C. 764−777.
- Rindi G., Kloppel G. Endocrine tumors of the gut and pancreas tumor biology and classification. // Neuroendocrinology. 2004. № 80 Suppl 1. C. 12−15.
- Robles-Diaz G., Fastag D. Cancer of the pancreas. Epidemiology and risk factors. // Rev Gastroenterol Mex. 2007. № 72 Suppl 2. C. 154−159.
- Rode J. h flp. PGP 9.5, a new marker for human neuroendocrine tumours. // Histopathology. 1985. № 9. C. 147−158.
- Roland C.F., van Heerden J.A. Nonpancreatic primary tumors with metastasis to the pancreas. // Surg Gynecol Obstet. 1989. № 168. C. 345−347.
- Roland C.L. hp. Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes. // J Surg Oncol. 2012. № 105. C. 595−600.
- Rosch T. h ap. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. //N Engl J Med. 1992. № 326. C. 1721−1726.
- Rosebrook J.L., Glickman J.N., Mortele K.J. Pancreatoblastoma in an adult woman: sonography, CT, and dynamic gadolinium-enhanced MRI features. // AJR Am J Roentgenol. 2005. № 184. C. S78−81.
- Rossi P. h flp. CT of functioning tumors of the pancreas. // AJR Am J Roentgenol. 1985. № 144. C. 57−60.
- Roy P.K. h flp. Zollinger-Ellison syndrome. Clinical presentation in 261 patients. // Medicine (Baltimore). 2000. № 79. C. 379−411.
- Ruszniewski P. h, ap. Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome. // Surgery. 1995. № 117. C. 629−635.
- Sabatini D.M. mTOR and cancer: insights into a complex relationship. // Nat Rev Cancer. 2006. № 6. C. 729−734.
- Sahni V.A., Mortele K.J. The bloody pancreas: MDCT and MRI features of hypervascular and hemorrhagic pancreatic conditions. // AJR Am J Roentgenol. 2009. № 192. C. 923−935.
- Samaan N.A. hp. Multiple endocrine syndrome type I. Clinical, laboratory findings, and management in five families. // Cancer. 1989. № 64. C. 741−752.
- Sander M. h? p. Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. // Genes Dev. 1997. № 11. C. 1662−1673.
- Sander M., German M.S. The beta cell transcription factors and development of the pancreas. // J Mol Med (Berl). 1997. № 75. C. 327−340.
- Sarbassov D.D. h ap. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. // Science. 2005. № 307. C. 1098−1101.
- Sarmiento J.M. hp. Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach. // Surgery. 2002. № 132. C. 973−976.
- Sarmiento J.M. h? jp. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. // J Am Coll Surg. 2003. № 197. C. 29−37.
- Scatarige J.C. h flp. Pancreatic parenchymal metastases: observations on helical CT. // AJR Am J Roentgenol. 2001. № 176. C. 695−699.
- Schonhoff S.E., Giel-Moloney M., Leiter A.B. Minireview: Development and differentiation of gut endocrine cells. // Endocrinology. 2004. № 145. C. 2639−2644.
- Schreinemakers J.M. h flp. The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review. // World J Surg. 2011. № 35. C. 1993−2005.
- Sellner F. h flp. Solitary and multiple isolated metastases of clear cell renal carcinoma to the pancreas: an indication for pancreatic surgery. // Ann Surg Oncol. 2006. № 13. C. 75−85.
- Semelka R.C. h, gp. Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. // J Magn Reson Imaging. 2000. № 11. C. 141−148.
- Sener S.F. h flp. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985−1995, using the National Cancer Database. // J Am Coll Surg. 1999. № 189. C. 1−7.
- Service F.J. h flp. Functioning insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study. // Mayo Clin Proc. 1991. № 66. C. 711 719.
- Service F.J., Natt N. The prolonged fast. // J Clin Endocrinol Metab. 2000. № 85. C. 3973−3974.
- Shah S., Mortele KJ. Uncommon solid pancreatic neoplasms: ultrasound, computed tomography, and magnetic resonance imaging features. // Semin Ultrasound CT MR. 2007. № 28. C. 357−370.
- Shi W. h pp. Localization of neuroendocrine tumours with 111 In. DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging. // QJM. 1998. № 91. C. 295−301.
- Shoup M. h, ap. The value of splenic preservation with distal pancreatectomy. // Arch Surg. 2002. № 137. C. 164−168.
- Siegel G.J. Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 6th edition. / no," pe#. B.W. Agranoff h flp. Philadelphia: Lippincott-Raven, 1999.
- Simon P., Spilcke-Liss E., Wallaschofski H. Endocrine tumors of the pancreas. // Endocrinol Metab Clin North Am. 2006. № 35. C. 431−47, xii.
- Skogseid B. hp. Limited tumor involvement found at multiple endocrine neoplasia type I pancreatic exploration: can it be predicted by preoperative tumor localization? // World J Surg. 1998. № 22. C. 673−678.
- Soga J., Tazawa K. Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases. // Cancer. 1971. № 28. C. 990−998.
- Solcia E., Kloppel G. S.L.H. World Health Organization: International Histological Classification of Tumors: Histological Typing of Endocrine Tumors. Berlin: Springer, 2000.
- Solorzano C.C. h zip. Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. // Surgery. 2001. № 130. C. 1078−1085.
- Sowa-Staszczak A. h flp. Are RECIST criteria sufficient to assess response to therapy in neuroendocrine tumors? // Clin Imaging. 2012. № 36. C. 360−364.
- Speer A.G. h flp. Pancreatic cancer: surgical management and outcomes after 6 years of follow-up. // Med J Aust. 2012. № 196. C. 511−515.
- Sperti C. h zip. Recurrence after resection for ductal adenocarcinoma of the pancreas. // World J Surg. 1997. № 21. C. 195−200.
- Stabile B.E., Morrow D.J., Passaro Jr. E. The gastrinoma triangle: operative implications. // Am J Surg. 1984. № 147. C. 25−31.
- Stafford-Johnson D.B. hp. Dual-phase helical CT of nonfunctioning islet cell tumors. // J Comput Assist Tomogr. 1998. № 22. C. 335−339.
- Stark D.D. h flp. CT of pancreatic islet cell tumors. // Radiology. 1984. № 150. C. 491−494.
- Starker L.F., Carling T. Molecular genetics of gastroenteropancreatic neuroendocrine tumors. // Curr Opin Oncol. 2009. № 21. C. 29−33.
- Stoica-Mustafa E. h, n, p. Pathological characteristics and clinical specifications in gastroenteropancreatic neuroendocrine tumors: a study of 68 cases. //Rom J Morphol Embryol. 2012. № 53. C. 351−355.
- St-Onge L. h flp. Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas. // Nature. 1997. № 387. C. 406−409.
- Stridsberg M. h? p. A panel of 13 region-specific radioimmunoassays for measurements of human chromogranin B. // Regul Pept. 2005. № 125. C. 193−199.
- Sugg S.L. h flp. A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas. // Ann Surg. 1993. № 218. C. 138−144.
- Sundin A. h, ap. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations. // Neuroendocrinology. 2009. № 90. C. 167−183.
- Sutliff V.E. h AP- Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns. // J Clin Oncol. 1997. № 15. C. 2420−2431.
- Tagaya N., Ishikawa K., Kubota K. Spleen-preserving laparoscopic distal pancreatectomy with conservation of the splenic artery and vein for a large insulinoma. // Surg Endosc. 2002. № 16. C. 217−218.
- Takamatsu S. h pp. Laparoscopic enucleation of an insulinoma of the pancreas tail. // Surg Endosc. 2002. № 16. C. 217.
- Tanis P.J. h flp. Systematic review of pancreatic surgery for metastatic renal cell carcinoma. // Br J Surg. 2009. № 96. C. 579−592.
- Taupenot L., Harper K.L., O’Connor D.T. The chromogranin-secretogranin family. // N Engl J Med. 2003. № 348. C. 1134−1149.
- Termanini B. h Ap. Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management. // Gastroenterology. 1997. № 112. C. 335−347.
- Terris B. h j? p. Expression of vascular endothelial growth factor in digestive neuroendocrine tumours. // Histopathology. 1998. № 32. C. 133−138.
- Teunissen J.J. hp. Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy. // Best Pract Res Clin Gastroenterol. 2005. № 19. C. 595−616.
- Thakker R.V. Multiple endocrine neoplasia type 1. // Endocrinol Metab Clin North Am. 2000. № 29. C. 541−567.
- Thoeni R.F. h ap. Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. // Radiology. 2000. № 214. C. 483−490.
- Thom A.K. h flp. Location, incidence, and malignant potential of duodenal gastrinomas. // Surgery. 1991. № 110. C. 1083−1086.
- Thomas-Marques L. h zip. Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. // Am J Gastroenterol. 2006. № 101. C. 266−273.
- Thompson G.B. h pp. Islet cell carcinomas of the pancreas: a twenty-year experience. // Surgery. 1988. № 104. C. 1011−1017.
- Thompson N.W. Multiple endocrine neoplasia type I. Surgical therapy. // Cancer Treat Res. 1997. № 89. C. 407−419.
- Thompson N.W. hp. MEN I pancreas: a histological and immunohistochemical study. // World J Surg. 1984. № 8. C. 561−574.
- Tjon A.T.R.T. h flp. MR, CT, and ultrasound findings of metastatic vipoma in pancreas. // J Comput Assist Tomogr. 1989. № 13. C. 142−144.
- Trede M., Schwall G., Saeger H.D. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. // Ann Surg. 1990. № 21 l.C. 447−458.
- Triponez F. h flp. Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas. // Ann Surg. 2006a. № 243. C.265−272.
- Triponez F. h Ap. Is surgery beneficial for MEN1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE. // World J Surg. 2006b. № 30. C. 654.
- Trump D. h, zjp. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). // QJM. 1996. № 89. C. 653−669.
- Truty M.J., Thompson G.B. Surgical treatment of Zollinger-Ellison syndrome in multiple endocrine neoplasia, type 1. // Mayo Clin Proc. 2005. № 80. C. 1530- author reply 1530−1.
- Tsiotos G.G., Farnell M.B., Sarr M.G. Are the results of pancreatectomy for pancreatic cancer improving? // World J Surg. 1999. № 23. C. 913−919.
- Tucker O.N., Crotty P.L., Conlon K.C. The management of insulinoma. // Br J Surg. 2006. № 93. C. 264−275.
- Visser B.C. h flp. Characterization of cystic pancreatic masses: relative accuracy of CT and MRI. // AJR Am J Roentgenol. 2007. № 189. C. 648−656.
- Wandzioch E., Zaret K.S. Dynamic signaling network for the specification of embryonic pancreas and liver progenitors. // Science. 2009. № 324. C. 17 071 710.
- Weber H.C. h flp. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. // Gastroenterology. 1995. № 108. C. 1637−1649.
- Wermer P. Genetic aspects of adenomatosis of endocrine glands. // Am J Med. 1954. № 16. C. 363−371.
- White R.R. Pancreatic neuroendocrine tumors: selection, selection, selection. //J Surg Res. 2011. № 167. C. 211−213.
- Wiedenmann B. h flp. Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumors: general recommendations by a consensus workshop. // World J Surg. 1998. № 22. C. 309−318.
- Wiedenmann B. h Ap- Synaptophysin: a marker protein for neuroendocrine cells and neoplasms. // Proc Natl Acad Sci USA. 1986. № 83. C. 3500−3504.
- Wiedenmann B., Pavel M., Kos-Kudla B. From targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumors. // Neuroendocrinology. 2011. № 94. C. 177−190.
- Winter J.M. h ap. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. // J Gastrointest Surg. 2006. № 10. C. 1191−1199.
- Yada K. h, gp. Laparoscopic resection for nonfunctioning small glucagon-producing tumor: report of a case and review of the literature. // J Hepatobiliary Pancreat Surg. 2003. № 10. C. 382−385.
- Yamamoto M. A general view of pancreatic cancer in Japan and a proposal for a more practical staging sistem. // International Journal of Clinical Oncology. 1999. № 4. C. 267−272.
- Yang Q. h Ap. Requirement of Mathl for secretory cell lineage commitment in the mouse intestine. // Science. 2001. № 294. C. 2155−2158.
- Yao J.C. h pp. Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study. // J Clin Oncol. 2008b. № 26. C. 4311−4318.
- Yao J.C. h flp. One hundred years after «carcinoid»: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. // J Clin Oncol. 2008a. № 26. C. 3063−3072.
- Yim J.H. h Prospective study of the utility of somatostatin-receptor scintigraphy in the evaluation of patients with multiple endocrine neoplasia type 1. // Surgery. 1998. № 124. C. 1037−1042.
- You Y.N. h, zjp. Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: Operative outcomes, long-term function, and quality of life. // Surgery. 2007. № 142. C. 829−36- discussion 836 el.
- Yu F. h flp. Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. // J Clin Oncol. 1999. № 17. C. 615−630.
- Z’Graggen K. h #p. Metastases to the pancreas and their surgical extirpation. // Arch Surg. 1998. № 133. c. 413−419.
- Zerbi A. h #p. Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection? // Ann Surg Oncol. 2008. № 15. C. 11 611 168.
- Zerbi A. h flp. Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases. // Langenbecks Arch Surg. 2011. № 396. C. 313−321.
- Zimmer T. h, qp. Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. // Gut. 1996. № 39. C. 562−568.
- Zimmer T. h ap. Endoscopic ultrasonography of neuroendocrine tumours. // Digestion. 2000. № 62 Suppl 1. C. 45−50.
- Zimmer T. h flp. Localisation of neuroendocrine tumours of the upper gastrointestinal tract. // Gut. 1994. № 35. C. 471−475.
- Zollinger R.M., Ellison E.H. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. // Ann Surg. 1955. № 142. C. 709−23- discussion, 724−8.
- Zollinger R.M., Ellison E.H. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. 1955. // CA Cancer J Clin. 1989. № 39. C. 231−247.